FMOC-LYS(FMOC)-OH

Fmoc-Lys(Fmoc)-OH >=98.0% (HPLC) FMOC-LYS(FMOC)-OH FMOC-LYSINE(FMOC)-OH FMOC-N-EPSILON-BIS-FMOC-D-LYSINE FMOC-N-EPSILON-BIS-FMOC-L-LYSINE N-2-N-6-BIS-FMOC-L-LYSINE N,N-BIS-FMOC-L-LYSINE N-ALPHA,E-DI-FMOC-L-LYSINE N-ALPHA,EPSILON-BIS-FMOC-L-LYSINE N-ALPHA,EPSILON-DI-FMOC-L-LYSINE N-ALPHA-,N-EPSILON-DI-FMOC-L-LYSINE N-ALPHA,N-EPSILON-DI-(9-FLUORENYLMETHOXYCARBONYL)-L-LYSINE N-ALPHA-N-EPSILON-BIS(9-FLUORENYLMETHYLOXYCARBONYL)-L-LYSINE N-ALPHA-N-EPSILON-BIS-FMOC-L-LYSINE FMOC-N-E-BIS-FMOC-D-LYSINE FMOC-N-E-BIS-FMOC-L-LYSINE N-α-Fmoc-Nε-Fmoc-L-lysine Nα,Nε-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine Nα,ε-Bis-Fmoc-L-lysine≥ 99.7% (HPLC, Chiral purity) N_α,N_ε-di-Fmoc-L-lysine N-α,N-ε-di-Fmoc-L-lysine Fmoc-Lys(From)-OH NALPHA,NEPSILON-Bis-(9-fluorenylmethoxycarbonyl)-L-lysine FMoc-Lys(FMoc)-OH N-α,N-ε-di-FMoc-L-lysine N^a,N^e-Di-FMoc-L-lysine, 98% Nalpha,Nepsilon-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine (S)-2,6-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoicacid (9H-Fluoren-9-yl)MethOxy]Carbonyl Lys(Fmoc)-OH (2S)-2,6-bis({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid Fmoc-Lys(Fmoc)-OH, 98.0% Nalpha,Nepsilon-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine > Fmoc-Lys(Fmoc)-OH,>98% FMOC-LYS(FMOC)-OH 5 G L-Lysine, N2,N6-bis[(9H-fluoren-9-ylmethoxy)carbonyl]- FMOC-LYS(FMOC)-OH USP/EP/BP Nα,ε-Bis-Fmoc-L-lysine Nα,Nε-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine FMOC-L-LYS(FMOC)-OH FMoc-Lys(FMoc) N2,N6-Bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine N-α,N-ε-di-Fmoc-L-lysine 78081-87-5 C36H34N2O6 Lysine Amino Acid Derivatives Peptide Synthesis Specialty Synthesis Amino Acids Lysine [Lys, K] Fmoc-Amino Acids and Derivatives Fmoc-Amino acid series pharmacetical